vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Phreesia, Inc.（PHR）财务数据对比。点击上方公司名可切换其他公司
Phreesia, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$120.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 12.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $12.2M）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Phreesia, Inc.是一家SaaS服务企业，为医疗机构提供多款应用软件，帮助机构实现患者登记分诊流程的自动化处理与高效管理，助力医疗流程优化，提升机构运营效率与患者就诊体验。
PBYI vs PHR — 直观对比
营收规模更大
PHR
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出15.0%
12.7%
自由现金流更多
PBYI
多$2.2M
$12.2M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $120.3M |
| 净利润 | — | $4.3M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 3.1% |
| 净利率 | — | 3.5% |
| 营收同比 | 27.7% | 12.7% |
| 净利润同比 | — | 129.7% |
| 每股收益（稀释后） | $0.26 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPHR
| Q4 25 | $75.5M | $120.3M | ||
| Q3 25 | $54.5M | $117.3M | ||
| Q2 25 | $52.4M | $115.9M | ||
| Q1 25 | $46.0M | — | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $80.5M | — | ||
| Q2 24 | $47.1M | — | ||
| Q1 24 | $43.8M | — |
净利润PBYIPHR
| Q4 25 | — | $4.3M | ||
| Q3 25 | $8.8M | $654.0K | ||
| Q2 25 | $5.9M | $-3.9M | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-4.8M | — |
毛利率PBYIPHR
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIPHR
| Q4 25 | 22.7% | 3.1% | ||
| Q3 25 | 17.6% | -1.3% | ||
| Q2 25 | 12.7% | -2.8% | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率PBYIPHR
| Q4 25 | — | 3.5% | ||
| Q3 25 | 16.2% | 0.6% | ||
| Q2 25 | 11.2% | -3.4% | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | -9.6% | — | ||
| Q1 24 | -11.0% | — |
每股收益（稀释后）PBYIPHR
| Q4 25 | $0.26 | $0.07 | ||
| Q3 25 | $0.17 | $0.01 | ||
| Q2 25 | $0.12 | $-0.07 | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $106.4M |
| 总债务越低越好 | $22.7M | $3.4M |
| 股东权益账面价值 | $130.3M | $320.3M |
| 总资产 | $216.3M | $423.5M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPHR
| Q4 25 | $97.5M | $106.4M | ||
| Q3 25 | $94.4M | $98.3M | ||
| Q2 25 | $96.0M | $90.9M | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYIPHR
| Q4 25 | $22.7M | $3.4M | ||
| Q3 25 | $34.0M | $4.6M | ||
| Q2 25 | $45.3M | $6.2M | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPHR
| Q4 25 | $130.3M | $320.3M | ||
| Q3 25 | $115.3M | $298.0M | ||
| Q2 25 | $104.7M | $282.2M | ||
| Q1 25 | $97.1M | — | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | — | ||
| Q2 24 | $48.5M | — | ||
| Q1 24 | $51.0M | — |
总资产PBYIPHR
| Q4 25 | $216.3M | $423.5M | ||
| Q3 25 | $202.9M | $408.6M | ||
| Q2 25 | $194.9M | $400.4M | ||
| Q1 25 | $196.2M | — | ||
| Q4 24 | $213.3M | — | ||
| Q3 24 | $220.7M | — | ||
| Q2 24 | $205.0M | — | ||
| Q1 24 | $214.1M | — |
负债/权益比PBYIPHR
| Q4 25 | 0.17× | 0.01× | ||
| Q3 25 | 0.30× | 0.02× | ||
| Q2 25 | 0.43× | 0.02× | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $12.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 10.1% |
| 资本支出强度资本支出/营收 | 0.0% | 2.7% |
| 现金转化率经营现金流/净利润 | — | 3.62× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIPHR
| Q4 25 | $14.4M | $15.5M | ||
| Q3 25 | $9.7M | $14.8M | ||
| Q2 25 | $14.1M | $14.8M | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $11.2M | — |
自由现金流PBYIPHR
| Q4 25 | $14.4M | $12.2M | ||
| Q3 25 | $9.7M | $13.1M | ||
| Q2 25 | $14.1M | $11.3M | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIPHR
| Q4 25 | 19.1% | 10.1% | ||
| Q3 25 | 17.7% | 11.1% | ||
| Q2 25 | 26.8% | 9.8% | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIPHR
| Q4 25 | 0.0% | 2.7% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIPHR
| Q4 25 | — | 3.62× | ||
| Q3 25 | 1.10× | 22.68× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PHR
| Subscription And Services | $55.5M | 46% |
| Network Solutions | $37.4M | 31% |
| Payment Processing Fees | $27.4M | 23% |
